A surprising observation from this list of mutations in normal tissue is the absence of known driver mutations in CRC such as APC, or KRAS, raising questions concerning the role of normal driver mutations in oncogenesis, if any, and whether such normal somatic mutations impact upon the later acquisition of CRC driver mutations. The gene discussed is KRAS; the disease is colorectal carcinoma.